US Medical Radiopharmaceuticals Market

New Growth Opportunities Emerge in a Strenuous Market

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

This research service pertains to the US market for medical radiopharmaceuticals. A thorough market sizing and forecasting model of market revenue, procedure volumes, and average pricing is included, along with analyses of market trends, drivers and restraints, and the reimbursement and the competitive environments at the total level as well as within each segment. The three market segments considered are diagnostic SPECT radiopharmaceuticals, diagnostic PET radiopharmaceuticals and therapeutic radiopharmaceuticals. The base year of the study is 2012 and the forecast period extends seven years through 2019.

Table of Contents

Executive SummaryExecutive SummaryExecutive Summary (continued)Executive Summary—Market Engineering MeasurementsExecutive Summary—Market Engineering Measurements (continued)Executive Summary—CEO’s PerspectiveMarket OverviewMarket Overview—DefinitionsMarket Overview—Definitions (continued)Market Overview—IntroductionMarket Overview—Distribution Structure and Clinical ApplicationsDistribution Structure and Clinical Applications DiscussionMarket Overview—Scope of StudyMarket Overview—Key Questions This Study Will AnswerMarket Overview—SegmentationMarket Overview—Segmentation (continued) External Challenges: Drivers and Restraints—Total Medical Radiopharmaceuticals MarketDrivers and RestraintsDrivers—Impact and DurationDrivers ExplainedDrivers Explained (continued)Drivers Explained (continued)Drivers Explained (continued)Drivers Explained (continued)Restraints—Impact and DurationRestraints ExplainedRestraints Explained (continued)Restraints Explained (continued)Restraints Explained (continued)Restraints Explained (continued)Restraints Explained (continued)Forecasts and Trends—Total Medical Radiopharmaceuticals MarketTotal Medical Radiopharmaceuticals Market— IntroductionTotal Medical Radiopharmaceuticals Market— Introduction (continued)Market Engineering MeasurementsMarket Engineering Measurements (continued)Forecast AssumptionsTotal Medical Radiopharmaceuticals Market—Revenue ForecastRevenue Forecast DiscussionRevenue Forecast Discussion (continued)Total Medical Radiopharmaceuticals Market—Revenue Forecast by SegmentRevenue Forecast by Segment DiscussionReimbursement Landscape Analysis—Total Medical Radiopharmaceuticals MarketRadiopharmaceutical Reimbursement—IntroductionReimbursement of Procedures Involving Use of RadiopharmaceuticalsReimbursement of Procedures Involving Use of Radiopharmaceuticals (continued)Reimbursement of Procedures Involving Use of Radiopharmaceuticals (continued)Reimbursed Radiopharmaceuticals Billing CodesReimbursed Radiopharmaceuticals Billing Codes (continued)Reimbursed Radiopharmaceuticals Billing Codes (continued)Reimbursed Radiopharmaceuticals Billing Codes (continued)Market Share and Competitive Analysis— Total Medical Radiopharmaceuticals MarketKey Industry Participants and Main Product LinesCompetitive Analysis—Market ShareMarket Share AnalysisRadiopharmacy Facility LandscapeCompetitive EnvironmentCompetitive Factors and AssessmentDiagnostic SPECT Radiopharmaceuticals Segment BreakdownDiagnostic SPECT Radiopharmaceuticals Segment BreakdownDiagnostic SPECT Radiopharmaceuticals Segment—Market Engineering MeasurementsDiagnostic SPECT Radiopharmaceuticals Segment—Revenue ForecastRevenue Forecast DiscussionRevenue Forecast Discussion (continued)Diagnostic SPECT Radiopharmaceuticals Segment—Procedure Volume ForecastProcedure Volume Forecast DiscussionDiagnostic SPECT Radiopharmaceuticals Segment—Pricing Trends and ForecastPricing Trends and Forecast DiscussionCompetitive Analysis—Market ShareMarket Share AnalysisDiagnostic PET Radiopharmaceuticals Segment BreakdownDiagnostic PET Radiopharmaceuticals Segment BreakdownDiagnostic PET Radiopharmaceuticals Segment—Market Engineering MeasurementsDiagnostic PET Radiopharmaceuticals Segment—Revenue ForecastRevenue Forecast DiscussionDiagnostic PET Radiopharmaceuticals Segment—Procedure Volume ForecastProcedure Volume Forecast DiscussionProcedure Volume Forecast Discussion (continued)Diagnostic PET Radiopharmaceuticals Segment—Pricing Trends and ForecastPricing Trends and Forecast DiscussionCompetitive Analysis—Market ShareMarket Share AnalysisRadioimmunotherapy AgentsSegment BreakdownRadioimmunotherapy Agents Segment—BackgroundRadioimmunotherapy Agents Segment—IntroductionRadioimmunotherapy Agents Segment BreakdownRadioimmunotherapy Agents Segment—Market Engineering MeasurementsRadioimmunotherapy Agents Segment—Revenue ForecastRevenue Forecast DiscussionRevenue Forecast Discussion (continued)Revenue Forecast Discussion (continued)Revenue Forecast Discussion (continued)Revenue Forecast Discussion (continued)The Last WordThe Last Word—Three Big PredictionsLegal DisclaimerAppendixMarket Engineering MethodologyLearn More—Next Steps




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 20-Nov-17

Region : North America

Release Date : 07-Nov-17

Region : North America

Release Date : 06-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.